Cardiac Assist Devices Market Size, Share & Trends Analysis Report By Product (Ventricular Assist Device (VAD) (LVAD, RIVAD, BIVAD) and Intra-Aortic Balloon Pump), By Modality, By End-Users, Region And Segment Forecasts, 2023-2031.

Report Id: 1236 Pages: 180 Last Updated: 08 November 2024 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Cardiac Assist Devices Market-

Cardiac Assist Devices Market by Modality

  • Transcutaneous
  • Implantable

Cardiac Assist Devices Market

Cardiac Assist Devices Market by Products

  • Ventricular Assist Device (VAD)
    • Left ventricular Assist Device (LVAD)
    • Right Ventricular Assist Device (RVAD)
    • Biventricular Assist Device (BIVAD)
    • External Ventricular Assist Devices
  • Intra-Aortic Balloon Pump

Cardiac Assist Devices Market by End-Users

  • Hospital
  • Ambulatory Surgical Centers

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Cardiac Assist Devices Market Snapshot

Chapter 4. Global Cardiac Assist Devices Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. Key Trends in the Market

4.8. COVID 19 Impact Analysis

Chapter 5. Cardiac Assist Devices Market Segmentation 1: By Modality Estimates & Trend Analysis

5.1. By Modality & Market Share, 2020 & 2030

5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Modality:

5.2.1. Transcutaneous

5.2.2. Implantable

Chapter 6. Cardiac Assist Devices Market Segmentation 2: By Products Estimates & Trend Analysis

6.1. By Products & Market Share, 2020 & 2030

6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Products:

6.2.1. Ventricular Assist Device (VAD)

6.2.1.1.  Left ventricular Assist Device (LVAD)

6.2.1.2.  Right Ventricular Assist Device (RVAD)

6.2.1.3.  Biventricular Assist Device (BIVAD)

6.2.1.4.  External Ventricular Assist Devices

6.2.2. Intra-Aortic Balloon Pump

Chapter 7. Cardiac Assist Devices Market Segmentation 3: By End-Users Estimates & Trend Analysis

7.1. By End-Users Analysis & Market Share, 2020 & 2030

7.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2022 to 2030 for the following By End-Users:

7.2.1. Hospital

7.2.2. Ambulatory Surgical Centers

Chapter 8. Cardiac Assist Devices Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Cardiac Assist Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Modality, 2020-2030

8.1.2. North America Cardiac Assist Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Products, 2020-2030

8.1.3. North America Cardiac Assist Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By End-Users, 2020-2030

8.1.4. North America Cardiac Assist Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2020-2030

8.1.4.1. U.S.

8.1.4.2. Canada

8.2. Europe

8.2.1. Europe Cardiac Assist Devices Market revenue (US$ Million) and volume (No. of Units) By Modality, 2020-2030

8.2.2. Europe Cardiac Assist Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Products, 2020-2030

8.2.3. Europe Cardiac Assist Devices Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2020-2030

8.2.4. Europe Cardiac Assist Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

8.2.4.1. Germany

8.2.4.2. Poland

8.2.4.3. France

8.2.4.4. Italy

8.2.4.5. Spain

8.2.4.6. UK

8.2.4.7. Rest of Europe

8.3. Asia Pacific

8.3.1. Asia Pacific Cardiac Assist Devices Market revenue (US$ Million) and volume (No. of Units) By Modality, 2020-2030

8.3.2. Asia Pacific Cardiac Assist Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Products, 2020-2030

8.3.3. Asia Pacific Cardiac Assist Devices Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2020-2030

8.3.4. Asia Pacific Cardiac Assist Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

8.3.4.1. China

8.3.4.2. India

8.3.4.3. Japan

8.3.4.4. Australia

8.3.4.5. Rest of Asia Pacific

8.4. Latin America

8.4.1. Latin America Cardiac Assist Devices Market revenue (US$ Million) and volume (No. of Units) By Modality, 2020-2030

8.4.2. Latin America Cardiac Assist Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Products, 2020-2030

8.4.3. Latin America Cardiac Assist Devices Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2020-2030

8.4.4. Latin America Cardiac Assist Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

8.4.4.1. Brazil

8.4.4.2. Rest of Latin America

8.5. MEA

8.5.1. MEA revenue Cardiac Assist Devices Market revenue (US$ Million) and volume (No. of Units) By Modality, 2020-2030

8.5.2. MEA Cardiac Assist Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Products, 2020-2030

8.5.3. MEA revenue Cardiac Assist Devices Market revenue (US$ Million) and volume (No. of Units) By End-Users, 2020-2030

8.5.4. MEA revenue Cardiac Assist Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2030

8.5.4.1. South Africa

8.5.4.2. Rest of MEA

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Terumo Corporation

9.2.2. Medtronic PLC

9.2.3. Maquet GmbH

9.2.4. Abbott Laboratories

9.2.5. Abiomed, Inc.

9.2.6. Balton Sp. z o.o

9.2.7. Berlin Heart GmbH

9.2.8. BiVACOR, Inc.

9.2.9. BioVentrix, Inc.

9.2.10. Calon Cardio-Technology Ltd

9.2.11. CardioBridge GmbH

9.2.12. Carmat SA (France)

9.2.13. CardiacBooster BV

9.2.14. CARDIAnove Inc

9.2.15. CorAssist Cardiovascular Ltd

9.2.16. Cleveland Heart, Inc.

9.2.17. CorWave S.A.

9.2.18. Evaheart, Inc.

9.2.19. FineHeart SARL

9.2.20. Fresenius Medical Care AG & Co. KGaA (Xenios AG)

9.2.21. GPB Life Science Holdings LLC (Insightra Medical, Inc.)

9.2.22. Getinge AB (Maquet Holding)

9.2.23. Jarvik Heart, Inc.

9.2.24. Livanova, PLC (Tandem Life)

9.2.25. Medtronic, PLC

9.2.26. MiTiHeart Corporation

9.2.27. OregonHeart

9.2.28. ReliantHeart, Inc.

9.2.29. Senko Medical Instrument Mfg. CO., LTD (Japan)

9.2.30. SynCardia Systems, LLC

9.2.31. Teleflex Incorporated

9.2.32. Windmill Cardiovascular Systems, Inc. (WCS)

9.2.33. Zeon Corporation

9.2.34. 8.3. List of Other Prominent Players

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
1220
Security Code field cannot be blank!

Frequently Asked Questions

Terumo Heart, Inc., Nova Pump GmbH, Getinge AB, Belton Ltd., Meryl Life Sciences Pvt. Ltd., Throated Corporation, Cardiac Assist, Inc., Berlin Heart G

The Cardiac Assist Devices Market is expected to grow at an 8.0 % CAGR during the forecast period for 2023-2031.

Product, Modality, and End-Users are the key segments of the Cardiac Assist Devices Market.

North American region is leading the Cardiac Assist Devices Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying